One of the main goals of ISAP is to be a forum for presenting new concepts and new data pertaining to the pharmacokinetics and pharmacodynamics of antiinfective agents. These new concepts and data may, possibly, become part of the basic science of antiinfective chemotherapy.
Over the years, the symposium, which ISAP helds just after the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) has become specifically devoted to this type "New concept/New data" discussion meeting (see "Past meetings and activities").
This year's meeting will be no exception to this rule and the programme will focus both on controversial issues, where new data and discussions are needed, as well as on the presentation of the and pharmacokinetics pharmacodynamics of new agents.
The
focus of the programme this year is also in bringing new views, and to
discuss new
topics. Effort will be made towards a real, in depth discussion
among
all participants based on presentations meant to be informative, and
even
sometimes provocative, but concentrating always on new concepts and
data
at the cutting edge of the Science of Pharmacokinetics and
Pharmacodynamics of Antiinfectives.
Programme
last update: October 21, 2004
Tuesday
November 2d, 2004
Organizer: Johan W. Mouton (Nijmegen, The Netherlands)
| 1:00
pm |
Registration and Lunch Buffet |
|
| 1:30 pm |
ISAP business meeting / General Assembly | |
| 2:30 pm | A Novel Pharmacodynamic Model of
Gatifloxacin (GAT) against Salmonella typhi in an in vitro Infection
Model O.O. Okusanya, A. Forrest, B.M. Booker, J.M. Bullock, P.G. Ambrose, S.M. Bhavnani, P.F. Smith |
|
| 2:50
pm |
A
Scoring Method Applicable to the Time-related Clinical and
Microbiological Responses of Patients with Staphylococcus aureus LTRI J.J. Schentag, P.M. Moise-Broder, M.H. Adelman, A. Forrest, |
|
| 3:10
pm |
In vitro
Pharmacodynamics of a Fluoroquinolone Against Anaerobes K.E. Bowker, A.R. Noel, A.P. MacGowan |
|
| 3:30
pm |
Pharmacodynamics and Pharmacokinetics of
Colistin and Colistin Methanesulfonate J. Li, R.L. Nation, R.W. Milne, J.D. Turnidge, K. Coulthard, C.R. Rayner |
|
| 3:50
pm |
Ex-Vivo Human
Placental Transfer of Indinavir S. Sudhakaran, H. Ghabrial, R.L. Nation, D.C.M. Kong, N.M. Gude, P.W. Angus, C.R. Rayner |
|
| 4:05 pm |
Inhibition of P-glycoprotein : Impact on
Placental Transfer of Indinavir S. Sudhakaran, C.R. Rayner H. Ghabrial, D.C.M. Kong, N.M. Gude, P.W. Angus, R.L. Nation |
|
| 4:20 pm |
Coffee / Tea and Poster viewing | |
| 4:40
pm |
Optimal
Multi-drug PK Sampling Strategies for Efavirenz and Indinavir Q. Ma, A. Forrest, S. Rosenkranz, M.F. Para, E. Adams, K. Yarasheski, R.C. Reichman, G.D. Morse, and the AACTG A5043 Protocol Team |
|
| 5:00
pm |
Optimal
Sparse Pharmacokinetic Sampling Strategies for Multi-Drug
Antiretroviral Regimens J. Zack, A. Forrest, Q. Ma, S. Rosenkranz, M.F. Para, E. Adams, K. Yarasheski, R.C. Reichman, G.D. Morse, and the AACTG A5043 Protocol Team |
|
| 5:20
pm |
A Population
Analysis Showing that Cystatin C is an as Good Predictor as Creatinin
Clearance for Cefuroxime Clearance. A. Viberg, M. Sandström, O. Cars, M. Karlsson. |
|
| 5:40 pm |
Pharmacokinetic and Pharmacodynamic
Evaluation of Ciprofloxacin in Modeled Microgravity E.L. Schuck, M. Grant, L. Putcha, H. Derendorf |
|
| 6:00 pm | Pharmacodynamics of
Cefprozil Against H. influenza in Plasma and Middle Ear Fluid by
Population Pharmacokinetic Modeling and Monte Carlo Simulation in
Otitis Media P.F. Smith, A. Forrest, B.M. Booker, S.M. Bhavnani, P.G. Ambrose |
|
| 6:20 pm |
Humanization and Adaptive Study Design- 2
Novel Approaches to Improving The Efficiency and Precision of PK/PD
Studies in Small Animals O.O. Okunsanya, A. Forrest, B.M. Booker, S.M. Bhavnani, D. Girard, P.G. Ambrose. |
|
| Closing Remarks and General Discussion | ||
![]() |
![]() |
||
![]() |
![]() |
Some quite
interesting (and perhaps less known) places ....
|